Skip to main content
Unified search: articles, nationwide company names, and robot categories (separate module)
Section content

Company Profile: Aethon

Published: Publisher: Zhilianhai Robotics News

Aethon at a glance

Aethon is recorded as a US supplier in mobile and logistics robotics, headquartered in Pittsburgh, PA, US.

Record status: VERIFIED (confidence 90).

This profile is compiled from public records only. It is not an endorsement, a certification or a commercial partnership.

Location and public contact

  • Headquarters: Pittsburgh, PA, US
  • Address: 48 26th Street, 15222
  • Website: https://aethon.com/
  • Phone: 412-322-2975

Contact details are taken from public records and may change. Confirm them on the official website before relying on them.

Products and systems on record

  • Zena RX Autonomous Mobile Robot (Zena RX) — status: active. Hospital autonomous mobile robot for secure medication and supply transport, with lockable payload space, autonomous navigation, workflow integration, elevator interaction, and fleet-management support.

A development status means public evidence of research or deployment; it does not mean the product is in volume production or on general sale.

Application industries

healthcare, hospital logistics, pharmacy

Source note

Compiled from the public company dataset snapshot dated 9 September 2026, which only includes records with verification status VERIFIED and confidence of at least 80. Primary public source: public record.

This article is published by the Zhilianhai Robotics News site. Where policies, standards, prices, company capabilities or project status are involved, cross-check the original sources as well.

Back to section

Company information

Company information in this section comes from the Zhilianhai company database. To add or correct company data, go to Company Directory to look up the company, or submit a data verification request via Contact Us; once the company data upload channel opens, this module will handle it.

Latest materials in this section

Discussion and comments